PRTN3 and rheumatoid arthritis: Based on multiple studies indicating that there is a prolonged preclinical stage for RA that is characterized by the presence of circulating RA autoantibodies such as ACPA and RF, in otherwise clinically unaffected individuals, illustrated in Figure 1, there are now several international initiatives aimed at preventing or delaying the onset of the disease [13,14].